Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays

Janine Maria Naim

Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays

Janine Maria Naim

Cleveland State University

Research output: Other contribution

Abstract

Cancer is the leading cause of death worldwide. The current treatment options available for lung cancer are limited and have drawbacks such as poor bioavailability, numerous side effects, poor efficacy and drug resistance. 3D model serve as a novel approach for drug screening purposes and the evaluation of compounds in the platform can help identify potent compounds for further in vivo xenograft studies.

Original language	American English
State	Published - Sep 6 2012
Externally published	Yes

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment
Medicine and Health Sciences
Other Analytical, Diagnostic and Therapeutic Techniques and Equipment
Pharmaceutics and Drug Design

Access to Document

Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors wFinal published version, 114 KBLicense: CC BY

Cite this

@misc{1de7f549e06b4adebcf619889f10f922,

title = "Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays",

abstract = " Cancer is the leading cause of death worldwide. The current treatment options available for lung cancer are limited and have drawbacks such as poor bioavailability, numerous side effects, poor efficacy and drug resistance. 3D model serve as a novel approach for drug screening purposes and the evaluation of compounds in the platform can help identify potent compounds for further in vivo xenograft studies.",

author = "Naim, \{Janine Maria\}",

year = "2012",

month = sep,

day = "6",

language = "American English",

type = "Other",

}

TY - GEN

T1 - Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays

AU - Naim, Janine Maria

PY - 2012/9/6

Y1 - 2012/9/6

N2 - Cancer is the leading cause of death worldwide. The current treatment options available for lung cancer are limited and have drawbacks such as poor bioavailability, numerous side effects, poor efficacy and drug resistance. 3D model serve as a novel approach for drug screening purposes and the evaluation of compounds in the platform can help identify potent compounds for further in vivo xenograft studies.

AB - Cancer is the leading cause of death worldwide. The current treatment options available for lung cancer are limited and have drawbacks such as poor bioavailability, numerous side effects, poor efficacy and drug resistance. 3D model serve as a novel approach for drug screening purposes and the evaluation of compounds in the platform can help identify potent compounds for further in vivo xenograft studies.

UR - https://engagedscholarship.csuohio.edu/u_poster_2012/26

M3 - Other contribution

ER -

Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays

Abstract

Disciplines

Access to Document

Other files and links

Cite this